Genmab | GEN - Passifs Courants

Prix De L'Action
1,694.00
Variation Quotidienne
4.00 0.24%
Mensuellement
-3.28%
Annuel
19.17%
Q2 Prévisions
1,628.53




Passifs Courants Changement Date
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Almirall EUR 350.64M 52.12M 2025-12
Amarin USD 179.64M 14.82M 2026-03
Amgen USD 24.96B 534M 2026-03
argenx SE USD 1.04B 371.99M 2025-06
AstraZeneca USD 32.57B 1.95B 2026-03
Bayer EUR 32.58B 3.63B 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Demant DKK 7.42B 1.63B 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Fresenius Medical Care EUR 6.25B 485.68M 2025-12
Galapagos EUR 152.86M 213.7M 2025-12
Genmab DKK 1.43B 686M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GN Store Nord DKK 7.32B 153M 2025-12
GRIFOLS EUR 2.02B 135.85M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.04B 405M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
UCB EUR 4.4B 470M 2025-12